Viewing nowColestop Tablets 5mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
White Life Science Co., Ltd.

MFDS item code 201405074 · Approved 2014.10.31 · Insurance code 625200970
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia where dietary measures and exercise are insufficient. It is also used as an adjunct therapy for patients with homozygous familial hypercholesterolemia. In particular, it lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It can also be used as an adjunct to diet in pediatric patients aged 10 to 17 years with familial heterozygous hypercholesterolemia who meet specific criteria. It also helps as an adjunct to diet in patients with primary dysbetalipoproteinemia. Lastly, it is used to reduce the risk of stroke, myocardial infarction, and vascular revascularization in high-risk patients with a high risk of cardiovascular disease. This medication is effectively used for various dyslipidemias and the reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dosage is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dosage may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams daily. 3. Older adults: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this drug 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dosage is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dosage for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Ages 10 ∼ 17 years: The usual dosage range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dosage should be adjusted individually according to the recommended treatment goal for each patient. Dosage adjustments should be made at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, patients who are allergic to this medication, have active liver disease, have muscle disorders, have severe renal impairment, or are pregnant or nursing should not take this medication. Moreover, this medication may affect liver function, so patients with a history of liver disease or those who consume alcohol should have their liver function tested before taking this medication, and regular liver enzyme tests should be performed during treatment. Muscle-related side effects may occur, so if symptoms such as muscle pain, weakness, or cramps appear, the doctor should be notified immediately. In particular, if muscle enzyme levels are elevated or muscle symptoms are severe, it may be necessary to discontinue the use of this medication. This medication may interact with other drugs, so patients currently taking any medications must inform their healthcare provider, as the blood concentration of this medication may increase when combined with certain drugs, raising the risk of side effects. Women who may become pregnant should use appropriate contraception while taking this medication, and this medication should not be used during pregnancy or if pregnancy is planned. There is no specific antidote for overdose; treatment should be symptomatic and liver function and muscle enzyme levels monitored. Dizziness and other symptoms may occur when driving or operating machinery, so caution is necessary. This medication contains lactose, so patients with lactose intolerance should not take it. Finally, during treatment with this medication, adverse reactions such as headache, dizziness, dyspepsia, skin rash, muscle pain may occur. If symptoms are severe or persistent, consult a healthcare professional.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, morbilliform drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This helps to safely preserve the effectiveness of the medication.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
White Life Science Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.